A history of growth and innovation
Bespak is founded supplying valves for cosmetics and consumer markets.
Bespak wins contract for Ventolin (GSK) and enters the pharmaceutical market.
Bespak moves to King’s Lynn, where we remain today.
Bespak launches the HFA valve to replace the CFC version.
Aesica is formed following a management buyout, based in Cramlington.
Aesica adds an API pilot plant to Cramlington.
Aesica acquires a second site at Queenborough, complete with international development centre.
The Group becomes Consort Medical plc.
The Group acquires The Medical House, a specialist in auto-injectors.
Bespak manufactures their 500 millionth Diskus® (GSK).
The Group enters the point of care diagnostics market in partnership with Atlas Genetics.
Aesica acquires new sites in Pianezza (Italy), Monheim and Zwickau (Germany).
Aesica invest £30m in Queenborough expansion.
Bespak unveils their Syrina®, Vapoursoft® and Lila® range of innovative injection devices.
Aesica introduce serialisation capabilities at Pianezza and continuous tablet manufacturing at Queenborough.
Bespak launches their first auto-injector (Dr. Reddy’s).
Consort Medical Group acquires Aesica.
Aesica introduce serialisation capabilities at Monheim.
Bespak manufactures their two billionth HFA MDI Valve.
Bespak expand King’s Lynn site, creating Europe’s largest clean room facility.
Bespak complete a major refurbishment programme across King’s Lynn and Cambridge upgrading office and laboratory work environments.